Aurobindo Pharma Limited has informed the Exchange regarding a press release dated August 01, 2023, titled "Aurobindo Pharma receives USFDA Approval for Saxagliptin Tablets, 2.5 mg and 5 mg.".
Aurobindo Pharma Limited has informed the Exchange regarding a press release dated August 01, 2023, titled "Aurobindo Pharma receives USFDA Approval for Saxagliptin Tablets, 2.5 mg and 5 mg.".